UAE Ministry of Health and Prevention transfers 44 core services to Emirates Drug Establishment, unifying regulation and improving effi...

Mubadala Bio opens a high-potency facility and launches three oncology drugs, enhancing UAE's pharmaceutical capabilities and drug secu...

The Emirates Drug Establishment reviews its achievements and sets strategic priorities for 2024-2026 to enhance innovation in the pharm...

Dr. Thani Al Zeyoudi's visit to Julphar highlights the UAE's commitment to pharmaceutical self-sufficiency and industry collaboration....

Julphar partners with AIM Congress 2025 to enhance global manufacturing and investment in the pharmaceutical sector....

Bandar Alkhorayef lays foundation for Sudair Pharma's insulin plant, enhancing local diabetes treatment production in Saudi Arabia....

Dr. Thani Al Zeyoudi visits Globalpharma to enhance the UAE's pharmaceutical sector and support local product competitiveness....

Mintiply Capital, a recognized leader in investment banking with a focus on wealth management, private equity, venture capital, and adv...

H.H. Sheikh Saif bin Zayed Al Nahyan visits DUPHAT 2025, witnessing the launch of a new pharmaceutical college aimed at advancing educa...

DUPHAT 2025 successfully recorded AED 9.35 billion in trade deals, showcasing the UAE's role in the global pharmaceutical market....

The Emirates Drug Establishment reviews key achievements and future plans, focusing on innovation and sustainability in the medical sec...

The CPHI Middle East exhibition concluded with strategic partnerships surpassing SAR 10 billion, highlighting the Kingdom's commitment ...

The CPHI Middle East exhibition begins in Riyadh, showcasing over 400 exhibitors and significant investments in the pharmaceutical sect...

Riyadh will host the CPHI Middle East exhibition from December 10-12, showcasing global pharmaceutical innovations and fostering intern...

The Saudi Food and Drug Authority has been elected to the ICH Management Committee, highlighting its commitment to global pharmaceutica...

Cambrex accelerates its $100 million investment plan, expanding capacity and technology in drug development and manufacturing ahead of ...